Pharma Tech

Lilly’s Mounjaro wins US label expansion for cardiovascular risk reduction

Aug 28, 2026, 2:15 PM

Read Full Article → Lilly’s Mounjaro wins US label expansion for cardiovascular risk reduction

Translate article text

Choose a language and wait for the translated text.

The new Mounjaro approval will likely expand Lilly’s cardiometabolic empire as it looks to stay ahead of rival Novo Nordisk.